Dr. Tinofa O. Muskwe, MD

Dr. Muskwe practices at Shasta Regional Medical Center in Redding, California, part of Prime Healthcare Services.

Dr. Muskwe's NPI, 1902861156, was assigned on April 19, 2006. Dr. Muskwe holds Mississippi license 20598.

Dr. Muskwe's primary practice is Shasta Regional Medical Center, at 1100 Butte St, Redding, CA 96001 in Shasta County. The practice phone is (530) 244-5454.

Dr. Muskwe's primary practice is Shasta Regional Medical Center in Redding, California, part of Prime Healthcare Services. Dr. Muskwe is also affiliated with Mercy Medical Center Redding. The medical group on file is Tripleaim Healthcare. Dmand AI also links Dr. Muskwe to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muskwe practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Muskwe's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Dr. Muskwe's licenses on file in 3 states: Mississippi, Iowa and Illinois.

CMS data shows 748 Medicare services from Dr. Muskwe across 3 procedure codes in 2024, for 150 Medicare patients. Medicare paid $98,491 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 150 Medicare patients who saw Dr. Muskwe in 2024. The largest group is 75 to 84, with 61 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 47% are also on Medicaid. Their average risk score is 2.31, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muskwe's median patient age at 69, with 40% women.

In 2022, Dr. Muskwe wrote 86 Medicare Part D claims. They cover 3 drugs, with $49,893 in total drug cost. In 2021, CMS named 278 claims across 9 drugs.

Dr. Muskwe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Muskwe from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 87% of the total. GlaxoSmithKline, LLC. paid the most, $414.